uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Evusheld
Withdrawn
Human
Details
EMA number
EMEA/H/C/005788
ATC code
-
Authorisation
25 March 2022
Withdrawn
12 September 2025
Revision
10
EMA page
Therapeutic indication
Prevention of COVID-19.
MeSH:
COVID-19 virus infection
Special characteristics
Additional monitoring
Active substances
tixagevimab
cilgavimab
Marketing Authorisation Holder
AstraZeneca AB
MAH
Timeline
Filter by authority:
EMA
Evusheld withdrawn
12 Sept 2025
withdrawn
regulatory
Evusheld authorised
25 Mar 2022
authorised
regulatory
Evusheld | uMedical